Chicago Rivet & Machine (CVR) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
7 Nov, 2025Executive summary
Sales for Q3 2025 increased 5.6% year-over-year to $7.36M, driven by higher automotive order volumes despite industry headwinds.
Net income for Q3 2025 was $67,572, a return to profitability from a $1.45M loss in Q3 2024, reflecting improved margins and cost management.
For the nine months ended September 30, 2025, sales declined 4.3% year-over-year to $21.9M, but net income improved to $73,615 from a $2.0M loss.
A one-time gain of $339,520 from the sale of the Albia facility contributed to year-to-date results.
Financial highlights
Gross margin for Q3 2025 rose to $1.33M (91.3% increase year-over-year); nine-month gross margin up 38.8% to $3.96M.
Selling and administrative expenses decreased 16.7% in Q3 2025 and 5.1% year-to-date, reflecting cost containment.
Operating income for Q3 2025 was $64,570, compared to a loss of $823,571 in Q3 2024.
Cash and cash equivalents at September 30, 2025 were $1.68M.
Working capital increased 8.7% to $11.27M since year-end.
Outlook and guidance
Management expects continued uncertainty due to tariffs, supply chain issues, and market volatility.
Strategic focus remains on cost reduction, efficiency improvements, and new sales opportunities.
Substantial doubt remains about the ability to continue as a going concern without successful execution of strategic actions.
Latest events from Chicago Rivet & Machine
- Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing2 Dec 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 202429 Sep 2025 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 202429 Sep 2025 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 202429 Sep 2025 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 202529 Sep 2025 - Sales and margins declined in Q2 2025, raising going concern doubts despite cost actions.CVR
Q2 202529 Sep 2025